上气道真菌微生物组与哮喘儿童未来失控及急性发作相关
本研究基于NCT02066129临床试验,对哮喘儿童上气道真菌组进行ITS1测序,基线194例、黄区107例。基线球马拉色菌相对丰度较高与未来黄区发作风险降低及首次黄区发作时间延长相关,黄区时球马拉色菌丰度较高与进展为重度急性发作风险降低相关。上气道真菌组从基线到黄区发生显著变化,真菌多样性增加与细菌多样性增加高度相关。
要点
- 基线球马拉色菌丰度较高与未来黄区发作风险降低及首次黄区发作时间延长相关。
- 黄区时球马拉色菌丰度较高与从黄区进展为重度哮喘急性发作风险降低相关。
- 上气道真菌组从基线到黄区显著变化,真菌多样性增加与细菌多样性增加高度相关。
核心结论
- 上气道共生真菌组与哮喘儿童未来哮喘控制相关。
- 该工作强调真菌群在哮喘控制中的重要性,可能有助于开发基于真菌的哮喘急性发作预测标志物。
研究设计与样本
- 研究耦合Step Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations临床试验(NCT02066129)。
- 采用ITS1测序分析哮喘儿童鼻吹样本上气道真菌组,基线(哮喘控制良好)n=194,黄区(哮喘失控早期迹象)n=107。
主要发现
- 基线时上气道样本检测到499个真菌属,以共生真菌种球马拉色菌和限制马拉色菌最为优势。
- 马拉色菌属相对丰度随年龄、BMI和种族变化。
- 基线球马拉色菌相对丰度较高与未来黄区发作风险降低相关(P = .038),与首次黄区发作时间延长相关(P = .022)。
- 黄区时球马拉色菌相对丰度较高与从黄区进展为重度哮喘急性发作风险降低相关(P = .04)。
- 上气道真菌组从基线到黄区发生显著变化,真菌多样性增加与细菌多样性增加高度相关(ρ = 0.41)。
临床怎么用
- 上气道真菌组(尤其球马拉色菌相对丰度)可能作为哮喘儿童未来失控和急性发作的预测指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accumulating evidence suggests that the upper airway bacterial microbiota is implicated in asthma inception, severity, and exacerbation. Unlike bacterial microbiota, the role of the upper airway fungal microbiome (mycobiome) in asthma control is poorly understood. RESEARCH QUESTION: What are the upper airway fungal colonization patterns among children with asthma and their relationship with subsequent loss of asthma control and exacerbation of asthma? STUDY DESIGN AND METHODS: The study was coupled with the Step Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (ClinicalTrials.gov Identifier: NCT02066129) clinical trial. The upper airway mycobiome was investigated using Internal transcribed spacer 1 (ITS1) sequencing of nasal blow samples collected from children with asthma when asthma was well controlled (baseline, n = 194) and during early signs of loss of asthma control (yellow zone [YZ], n = 107). RESULTS: At baseline, 499 fungal genera were detected in the upper airway samples, with two commensal fungal species, Malassezia globosa and Malassezia restricta, being most dominant. The relative abundance of Malassezia species varies by age, BMI, and race. Higher relative abundance of M globosa at baseline was associated with lower risk of future YZ episodes (P = .038) and longer time to development of first YZ episode (P = .022). Higher relative abundance of M globosa at YZ episode was associated with lower risk of progression from YZ episode to severe asthma exacerbation (P = .04). The upper airway mycobiome underwent significant changes from baseline to YZ episode, and increased fungal diversity was correlated highly with increased bacterial diversity (ρ = 0.41). INTERPRETATION: The upper airway commensal mycobiome is associated with future asthma control. This work highlights the importance of the mycobiota in asthma control and may contribute to the development of fungi-based markers to predict asthma exacerbation.
引用
- Yuan, Liu, Dong, et al. The Fungal Microbiome of the Upper Airway Is Associated With Future Loss of Asthma Control and Exacerbation Among Children With Asthma. Chest. 2023. PMID: 37003356. doi:10.1016/j.chest.2023.03.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。